Press release
Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials Market
According to the latest research by InsightAce Analytic, the Global Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials Market is valued at US$ 19.49 Bn in 2023, and it is expected to reach US$ 33.61 Bn by 2031, with a CAGR of 7.20% during the forecast period of 2024-2031.
Request For Free Sample Pages:
https://www.insightaceanalytic.com/request-sample/2311
Chronic obstructive pulmonary disease (COPD) encompasses a group of progressive lung disorders that lead to breathing difficulties, primarily including emphysema and chronic bronchitis. One of the hallmark symptoms of COPD is impaired respiratory function. A significant factor anticipated to drive the growth of the COPD market is the rising global prevalence of the disease. Additionally, the market is expected to expand over the forecast period, fueled by increasing rates of cigarette smoking among younger populations and heightened public awareness regarding the benefits of utilizing generic medications for treatment.
List of Prominent Players in the Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials Market:
• AstraZeneca
• Boehringer Ingelheim International GmbH
• CHIESI Pharmaceutics S.p.A.
• Glaxo SmithKline plc
• Mylan N.V.
• Novartis AG
• Sunovion Pharmaceuticals, Inc. (Sumitomo Dainippon Pharma Co., Ltd.
• Teva Pharmaceutical Industries Ltd
• Pfizer Inc.
• Almirall
• Astellas Pharma
• Sanofi
Market Dynamics:
Drivers-
The increasing global prevalence of chronic obstructive pulmonary disease (COPD) is a primary driver for the growth and demand in the COPD market. Additionally, the rising rate of tobacco smoking among younger populations, coupled with growing public awareness about the benefits of generic medications, is expected to further propel market expansion. Moreover, the surge in healthcare spending, particularly in emerging economies, is improving access to COPD treatment. Increased awareness in both developing and underdeveloped regions is also anticipated to contribute significantly to market growth.
Curious About This Latest Version of The Report? Enquiry Before Buying: https://www.insightaceanalytic.com/enquiry-before-buying/2311
Challenges:
COPD is a chronic condition that typically requires long-term management and specialized treatment, both of which can be expensive. Many patients with COPD also suffer from comorbid conditions, further escalating healthcare costs. For a significant number of patients, the financial burden of COPD treatment presents a major barrier to access, especially in low-income countries with high healthcare costs and limited insurance coverage.
Regional Trends:
North America is expected to maintain a dominant share of the COPD clinical trials market, growing at a robust rate during the forecast period. Factors contributing to this growth include the high prevalence of COPD, a sophisticated healthcare infrastructure, the presence of leading pharmaceutical companies, and a favorable regulatory environment. COPD is a leading cause of death and disability in the United States, affecting approximately 16 million individuals, which drives the demand for COPD treatments. Additionally, North America's well-established healthcare system, supported by a vast network of hospitals, clinics, and pharmacies, plays a pivotal role in diagnosing, treating, and managing COPD, further contributing to the market's growth.
Recent Developments:
• In March 2023, A Phase 3 clinical trial for chronic obstructive pulmonary disease was successfully concluded by Sanofi and Regeneron with their anti-inflammatory medication. This accomplishment presents Dupixent, the medication, with the chance to become the inaugural biologic therapy to obtain authorization for the condition.
• In April 2022, GlaxoSmithKline Pharmaceuticals introduced Trelegy Ellipta for people with COPD. Trelegy Ellipta is India's first once-daily single-inhaler triple treatment (SITT) for COPD patients.
For More Customization @ https://www.insightaceanalytic.com/customisation/2311
Segmentation of Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials Market-
By Drug Class -
• Bronchodilators
• Combination
• Corticosteroids
• Phosphodiesterase
By Type
• Chronic Bronchitis
• Emphysema
By Distribution Channel
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• Southeast Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa
Get More Information:
https://www.insightaceanalytic.com/report/chronic-obstructive-pulmonary-disease-copd-clinical-trials-market/2311
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.https://www.insightaceanalytic.com/images_data/148861653.JPG
Contact Us:
info@insightaceanalytic.com
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 607 400-7072
Asia: +91 79 72967118
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
Twitter: https://twitter.com/Insightace
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials Market here
News-ID: 4064610 • Views: …
More Releases from Insightace Analytic Pvt Ltd.
Lentiviral Vector (LVV) CDMO Services Market expected to Witness Huge Revenue Gr …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Lentiviral Vector (LVV) CDMO Services Market - (By Type (IIT Grade, IND Grade, Clinical Trial Grade, Commercial Production Grade), By Application (Biopharmaceutical Company, Academic Scientific Research Institution)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic, the Global Lentiviral Vector (LVV) CDMO Services Market is expected to develop…
Artificial Intelligence in Livestock Farming Market Current Scenario with Future …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Artificial Intelligence in Livestock Farming Market- by Component (Solution/ Software/ App, IoT Sensors, and Services), Application (Real-Time Livestock Behavior Monitoring, Healthcare & Disease Monitoring, Livestock Feed & Water Monitoring, Livestock Control & Fencing Management, and Livestock Production Management), Type (Semi-Automatic and Fully-Automatic), Farm Size (Small and Medium-Sized Farms and Large Sized Farms), Technology (Computer Vision,…
Implantable Loop Recorder Market Exclusive Report on Current Trends and Future I …
"Implantable Loop Recorder Market" in terms of revenue was estimated to be worth $ 1.77 billion in 2024 and is poised to reach $ 4.45 billion by 2034, growing at a CAGR of 9.8% from 2025 to 2034 according to a new report by InsightAce Analytic.
Request For Free Sample Pages:
https://www.insightaceanalytic.com/request-sample/2149
Latest Drivers Restraint and Opportunities Market Snapshot:
Key factors influencing the global Implantable Loop Recorder Market are:
• Increasing prevalence of…
Beer Processing Market Study Analysis with Forecast to 2034
"Beer Processing Market" in terms of revenue was estimated to be worth $772.18 billion in 2023 and is poised to reach $ 1,341.1 billion by 2034, growing at a CAGR of 5.4% from 2025 to 2034 according to a new report by InsightAce Analytic.
Get Free Sample Report @
https://www.insightaceanalytic.com/request-sample/1529
Latest Drivers Restraint and Opportunities Market Snapshot:
Key factors influencing the global Beer Processing Market are:
• Increasing Consumer Demand For Craft…
More Releases for COPD
Copd Drugs Market Size Analysis by Application, Type, and Region: Forecast to Co …
USA, New Jersey- According to Market Research Intellect, the global Copd Drugs market in the Internet, Communication and Technology category is projected to witness significant growth from 2025 to 2032. Market dynamics, technological advancements, and evolving consumer demand are expected to drive expansion during this period.
Because respiratory problems are becoming more common worldwide, especially among smokers and older populations, the market for COPD medications is expanding steadily. The need…
Chronic Obstructive Pulmonary Disease (COPD) Treatment Market 2024-2030 Growth: …
Growth: Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Insights :
For stakeholders, an optimistic view is shown by the thorough study of the worldwide "Chronic Obstructive Pulmonary Disease (COPD) Treatment market". The research provides specifics on the market's historical and present conditions as well as projected trends and size. Decision-makers may navigate the competitive environment and investment possibilities in the Chronic Obstructive Pulmonary Disease (COPD) Treatment market with the use of…
Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Market - Breathing Sol …
Newark, New Castle, USA - new report, titled Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Chronic Obstructive Pulmonary Disease (COPD) Therapeutics market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Chronic Obstructive Pulmonary Disease…
Asthma & COPD Drugs Market - Breathe Freely, Live Fully: Empowering Respiratory …
Newark, New Castle, USA - new report, titled Asthma & COPD Drugs Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Asthma & COPD Drugs market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Asthma & COPD Drugs market. The report offers…
Copd CBD Gummies: Reviews (Shocking Facts) Copd CBD Oil "Ingredients" Pain Relie …
Copd CBD Gummies: With the increasing need for both individual and expert degrees, the stress and also stress are also enhancing. Individuals are using various methods to fight it. However, as a result of much less time for self, it is really hard. Here the natural herbs and supplements have actually discovered their way into our lives. The Copd CBD Oil are instances of super-effective natural supplements. The CBD existing…
Power Harmonica to Cure Chronic Asthma & COPD
Power Harmonica is a free reed wind musical instrument. It is small rectangular shaped musical instrument. It has 48 number of holes which makes it special and different from other harmonica's.
It's a pocket-friendly musical instrument. Power Harmonica is used as a natural treatment for many types of lung disorders and has no side effects. To play Power Harmonica there is no need of having a musical background it can be…
